USPTO trademark

AMNIOXPRESS

AllowedUSPTOWord markClass 5

"AMNIOXPRESS" is a word mark owned by MiMedx Group, Inc., filed at the USPTO on April 22, 2024. It has been allowed and covers class 5 (Pharmaceuticals).

View MiMedx Group, Inc. portfolioGet this data via the API
Official USPTO record
AMNIOXPRESS trademark as filed
As filed with the USPTO
Status
Allowed
Since May 13, 2026
Filed
April 22, 2024
Registered
Not yet
Expires
Not recorded
Application no.
98512922
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns AMNIOXPRESS

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

MiMedx Group, Inc.

MDXG · Marietta, United States

52 trademarks in the portfolioView company

Representative

Marcy L. Sperry, Esq.

Sperry IP Law LLC dba Vivid IP

Goods and services

What the mark covers

The products and services AMNIOXPRESS is filed for, grouped by Nice class.

  • Human biological amniotic membrane tissue intended for subsequent implantation; topical treatment in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; Topical treatment in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; topical treatment made from amniotic material in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; topical treatment made from amniotic material in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; wound treatment in the nature of a dressing comprising amniotic material; allograft made from amniotic material

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of approval of extension request e-mailed
  2. Sou extension 3 granted
  3. Sou extension 3 filed
  4. Sou teas extension received
  5. Notice of approval of extension request e-mailed
  6. Sou extension 2 granted
  7. Sou extension 2 filed
  8. Sou teas extension received
  9. Notice of approval of extension request e-mailed
  10. Sou extension 1 granted

10 earlier steps on the official record.

FAQ

About AMNIOXPRESS

Who owns the trademark "AMNIOXPRESS"?

The USPTO trademark "AMNIOXPRESS" (application 98512922) is owned by MiMedx Group, Inc.

What is the status of "AMNIOXPRESS"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull AMNIOXPRESS and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2cd2-eed8-771b-be7f-f6f0899ec830
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2cd2-eed8-771b-be7f-f6f0899ec830",
  "object": "trademark",
  "mark_text": "AMNIOXPRESS",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "98512922",
  "filing_date": "2024-04-22",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "MiMedx Group, Inc.",
      "entity_id": "ent_019eb705-84a2-725f-b3e2-b5203a49efac"
    }
  ]
}